Showing 1861-1870 of 3858 results for "".
Key Characteristics That Drive Practice Valuation
https://practicaldermatology.com/topics/practice-management/key-characteristics-that-drive-practice-valuation/20417/It makes good business sense to optimize value, whether looking to sell soon, in the future, or never.Therapeutics Update
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/theraputics-update/20510/New products and pharmacologic developmentsWhat's Next in Aesthetic Medicine?
https://practicaldermatology.com/topics/practice-management/whats-next-in-aesthetic-medicine/20523/Insights on the future of cosmetic care from DermTube.com.5 Tech Trends Your Dermatology Practice Can Leverage Today
https://practicaldermatology.com/topics/practice-management/5-tech-trends-your-dermatology-practice-can-leverage-today/20400/Dermatologists who review leading and upcoming trends can stay ahead of the curve.Updates from CSF 2017
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-updates-from-csf-2017/18371/Dermatologists and core cosmetic physicians shared new insights and reviewed the developments in clinical and cosmetic dermatology at the ninth annual Cosmetic Surgery Forum in Las Vegas. Matthew Zirwas, MD addressed interest in oral supplements to support skin health. Neurotoxin pioneer Nick Lowe,eRelevance Uncovers Marketing Truths, EADV Data, Primetime for Botox
https://practicaldermatology.com/series/dermwire-tv/erelevance-uncovers-marketing-truths-eadv-data-primetime-for-botox/18429/The State of Aesthetic Healthcare Marketing 2017 from eRelevance shows that nearly 60 percent of aesthetic physicians say they either don't see results from their marketing initiatives or aren't able to measure results. Data presented at the annual meeting of the European Academy of Dermatology andRhofade Approved, Sun Leaves Acne Behind, Radiesse Turns 10
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-rhofade-approved-sun-leaves-acne-behind-radiesse-turns-10/18552/The FDA has approved Allergan's Rhofade (Oxymetazoline 1%) cream for the topical treatment of persistent facial erythema associated with rosacea in adults. New research from Olay in collaboration with personal genetics company 23andMe shows that taking care of the skin may be the key to looking upThe Inside Scoop on Cosmeceuticals: From Top to Bottom
https://practicaldermatology.com/topics/general-topics/the-inside-scoop-on-cosmeceuticals-from-top-to-bottom/20896/Top derms dish about their favorite cosmeceuticals, including options beyond wrinkle fighting.New Products
https://practicaldermatology.com/columns/new-products/new-products/20961/Increasing Patient Satisfaction with Aesthetic Procedures
https://practicaldermatology.com/topics/skin-cancer-photoprotection/increasing-patient-satisfaction-with-aesthetic-procedures/21085/To enhance patient satisfaction, focus on optimizing the patient experience in all phases of care.